27.8 USD
+0.03 (+0.11%)
CHSCP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 87 industry peers in the Food Products industry. Both the profitability and financial health of CHSCP have multiple concerns. CHSCP has a expensive valuation and it also scores bad on growth. CHSCP also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
CHSCP had a positive operating cash flow in the past year.
In the past 5 years CHSCP has always been profitable.
In the past 5 years CHSCP always reported a positive cash flow from operatings.
1.2 Ratios
CHSCP's Return On Assets of 3.17% is in line compared to the rest of the industry. CHSCP outperforms 58.62% of its industry peers.
CHSCP has a Return On Equity (5.40%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 0.49%, CHSCP is doing worse than 60.92% of the companies in the same industry.
CHSCP had an Average Return On Invested Capital over the past 3 years of 3.89%. This is significantly below the industry average of 28.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROIC | 0.49% |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
1.3 Margins
CHSCP has a Profit Margin of 1.69%. This is comparable to the rest of the industry: CHSCP outperforms 49.43% of its industry peers.
In the last couple of years the Profit Margin of CHSCP has grown nicely.
Looking at the Operating Margin, with a value of 0.26%, CHSCP is doing worse than 62.07% of the companies in the same industry.
In the last couple of years the Operating Margin of CHSCP has declined.
Looking at the Gross Margin, with a value of 3.21%, CHSCP is doing worse than 88.51% of the companies in the same industry.
In the last couple of years the Gross Margin of CHSCP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% |
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHSCP is destroying value.
Compared to 1 year ago, CHSCP has a worse debt to assets ratio.
2.2 Solvency
CHSCP has an Altman-Z score of 2.32. This is not the best score and indicates that CHSCP is in the grey zone with still only limited risk for bankruptcy at the moment.
CHSCP's Altman-Z score of 2.32 is in line compared to the rest of the industry. CHSCP outperforms 56.32% of its industry peers.
A Debt/Equity ratio of 0.26 indicates that CHSCP is not too dependend on debt financing.
CHSCP's Debt to Equity ratio of 0.26 is fine compared to the rest of the industry. CHSCP outperforms 63.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.32 |
ROIC/WACC0.09
WACC5.55%
2.3 Liquidity
A Current Ratio of 1.53 indicates that CHSCP should not have too much problems paying its short term obligations.
CHSCP's Current ratio of 1.53 is in line compared to the rest of the industry. CHSCP outperforms 44.83% of its industry peers.
A Quick Ratio of 0.91 indicates that CHSCP may have some problems paying its short term obligations.
CHSCP has a Quick ratio (0.91) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 |
3. Growth
3.1 Past
Looking at the last year, CHSCP shows a decrease in Revenue. The Revenue has decreased by -9.68% in the last year.
The Revenue has been growing slightly by 4.54% on average over the past years.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHSCP indicates a rather cheap valuation: CHSCP is cheaper than 91.95% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 2.49 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHSCP has a Yearly Dividend Yield of 7.63%, which is a nice return.
Compared to an average industry Dividend Yield of 2.42, CHSCP pays a better dividend. On top of this CHSCP pays more dividend than 94.25% of the companies listed in the same industry.
CHSCP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.63% |
5.2 History
CHSCP has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCP has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years21
5.3 Sustainability
28.20% of the earnings are spent on dividend by CHSCP. This is a low number and sustainable payout ratio.
DP28.2%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:CHSCP (12/26/2025, 8:00:00 PM)
27.8
+0.03 (+0.11%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners11.45%
Inst Owner Change0.8%
Ins Owners0.04%
Ins Owner Change0%
Market Cap341.11M
Revenue(TTM)35.46B
Net Income(TTM)598.13M
Analysts0
Price TargetN/A
Short Float %0.04%
Short Ratio0.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 7.63% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP28.2%
Div Incr Years0
Div Non Decr Years21
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | 0.54 | ||
| P/B | 0.03 | ||
| P/tB | 0.03 | ||
| EV/EBITDA | 2.49 |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-7.56
FCFYN/A
OCF(TTM)51.82
OCFY186.39%
SpS2890.18
BVpS902.75
TBVpS902.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.17% | ||
| ROE | 5.4% | ||
| ROCE | 0.67% | ||
| ROIC | 0.49% | ||
| ROICexc | 0.5% | ||
| ROICexgc | 0.5% | ||
| OM | 0.26% | ||
| PM (TTM) | 1.69% | ||
| GM | 3.21% | ||
| FCFM | N/A |
ROA(3y)6.36%
ROA(5y)6.23%
ROE(3y)11.28%
ROE(5y)11.55%
ROIC(3y)3.89%
ROIC(5y)4.02%
ROICexc(3y)4.33%
ROICexc(5y)4.38%
ROICexgc(3y)4.41%
ROICexgc(5y)4.46%
ROCE(3y)5.12%
ROCE(5y)5.34%
ROICexgc growth 3Y-59.71%
ROICexgc growth 5Y-22%
ROICexc growth 3Y-59.75%
ROICexc growth 5Y-22.29%
OM growth 3Y-52.33%
OM growth 5Y-23.53%
PM growth 3Y-21.71%
PM growth 5Y2.56%
GM growth 3Y-10.36%
GM growth 5Y-1.5%
F-Score5
Asset Turnover1.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.26 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.9 | ||
| Cap/Depr | 111.84% | ||
| Cap/Sales | 2.05% | ||
| Interest Coverage | 0.62 | ||
| Cash Conversion | 85.64% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.91 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.55%
ROIC/WACC0.09
Cap/Depr(3y)119.46%
Cap/Depr(5y)96.76%
Cap/Sales(3y)1.78%
Cap/Sales(5y)1.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-9.47%
Revenue growth 5Y4.54%
Sales Q2Q%-6.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.43%
EBIT growth 3Y-56.84%
EBIT growth 5Y-20.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-119.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.05%
OCF growth 3Y-31.13%
OCF growth 5Y-10.17%
CHS INC - CHSINC 8 PERP / CHSCP FAQ
What is the fundamental rating for CHSCP stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHSCP.
What is the valuation status for CHSCP stock?
ChartMill assigns a valuation rating of 1 / 10 to CHS INC - CHSINC 8 PERP (CHSCP). This can be considered as Overvalued.
Can you provide the profitability details for CHS INC - CHSINC 8 PERP?
CHS INC - CHSINC 8 PERP (CHSCP) has a profitability rating of 3 / 10.
How financially healthy is CHS INC - CHSINC 8 PERP?
The financial health rating of CHS INC - CHSINC 8 PERP (CHSCP) is 3 / 10.